Kimberly S. Marshall, M.D. Becomes An InTone Specialist
InControl Medical has certified Kimberly S. Marshall, M.D. to prescribe InTone for women with bladder leakage.
Bedford, Texas (PRWEB) September 10, 2012
Dr. Kimberly S. Marshall, M.D. is a graduate of the University of Texas and the University Texas Southwestern Medical School in Dallas, Texas. Dr. Marshall completed her residency at the University Medical Center Brackenridge in Austin, Texas. Dr. Marshall is excited to offer her surgical patients the option of having a better choice for minimally-invasive procedures. Dr. Marshall is one of the few elite surgeons trained and certified on both Single Incision Laparoscopic Surgery (SILStm) and the da Vinci Surgical System. She is also very pleased to offer the innovative non-surgical InTone device to treat her patients with unwanted bladder leakage. When she is not seeing patients or delivering babies, Dr. Marshall loves going to movies, running, and spending time with her family.
Urinary incontinence is a condition that affects at least 20% percent of women in the United States alone. In fact, some estimates bring this number up to 45% if including women who are undiagnosed. Additionally, approximately 25% of new mothers have unexpected urinary leakage after a vaginal delivery and about 16% of women have leakage following cesarean section.
InTone, from InControl Medical, is a combination therapy device designed to stop urinary incontinence in females who have been diagnosed with stress, urge, or mixed incontinence. InControl Medical is convinced InTone will significantly improve bladder leakage for those who have followed the recommended protocol with medical supervision and will refund the cost of the device minus a small disposal fee if the patient´s condition does not improve. InControl Medical is the only company in this field with the confidence to guarantee its product.
To contact Kimberly S. Marshall, M.D. visit http://www.gen-obgyn.com
For the original version on PRWeb visit: http://www.prweb.com/releases/prweb2012/9/prweb9886597.htm